Research Article
Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation
| | Sex | Age
(year) | Protopathy | LVEF
(%) | LA
(mm) | RA
(mm) | LV
(mm) | Hypertension | Diabetes mellitus | Drugs |
| | Sinus rhythm () | M | 29 | Bicuspid aortic valves | 73.0 | 3.4 | 3.3 | 7.2 | No | No | Diuretics | | F | 62 | Coronary heart disease | 37.2 | 3.7 | 3.9 | 3.9 | Yes | Yes | Diuretics, calcium-channel blockers; nitrates | | M | 80 | Coronary heart disease | 44.6 | 3.9 | 4.3 | 5.0 | Yes | No | Diuretics, nitrates | | M | 70 | Coronary heart disease | 61.5 | 5.0 | | 4.6 | Yes | Yes | No | | F | 76 | Coronary heart disease | 45.1 | 3.2 | | 4.2 | Yes | Yes | Nitrates | | F | 57 | Coronary heart disease | 76.1 | 3.7 | | 4.4 | Yes | No | Calcium-channel blockers; nitrates | | M | 52 | Coronary heart disease | 48.7 | 4.0 | 4.0 | 5.3 | Yes | No | Nitrates | | … | | … | | | | | … | … | … | | AF () | F | 66 | Mitral valve prolapse | 79.4 | 6.4 | 5.3 | 6.2 | Yes | No | Diuretics | | M | 71 | Mitral valve prolapse | 61.2 | 5.8 | 6.5 | 5.7 | Yes | No | Diuretics, nitrates | | M | 56 | Coronary heart disease | 47.4 | 4.0 | 5.0 | 5.7 | No | No | No | | M | 51 | Atrial septal defect | 59 | 5.5 | 6.5 | 4.6 | No | No | Diuretics | | F | 64 | Mitral stenosis | 48.6 | 4.6 | 5.8 | 4.0 | No | No | Diuretics | | M | 77 | Atrial fibrillation | 51.8 | 5.1 | 5.7 | 6.1 | Yes | Yes | Calcium-channel blockers; nitrates | | F | 79 | Coronary heart disease | 68.3 | 4.0 | 5.4 | 4.8 | No | Yes | Nitrates, diuretics | | F | 54 | Mitral regurgitation | 50.7 | 5.1 | 5.0 | 5.7 | No | Yes | Calcium-channel blockers; nitrates | | … | | … | | | | | … | … | … |
|
|
M: male; F: female; LVEF: left ventricular ejection fraction; LA: left atrium; RA: right atrium; LV: left ventricle; vs. the sinus rhythm. |
